Wenjin Du, Ke Yang, Qiuxing Zhang, Xianghua Lin, Wenchao Zhang, Weili Guo, Zhaoji Meng, Siqin Wang
{"title":"Case Report: Identification of a novel mutation, c.1067T > A, in the <i>SERPING1</i> gene in a Chinese male with type 1 hereditary angioedema.","authors":"Wenjin Du, Ke Yang, Qiuxing Zhang, Xianghua Lin, Wenchao Zhang, Weili Guo, Zhaoji Meng, Siqin Wang","doi":"10.3389/falgy.2025.1554940","DOIUrl":null,"url":null,"abstract":"<p><p>Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder characterized by recurrent, unpredictable episodes of angioedema that commonly involve the face, limbs, respiratory tract, and gastrointestinal tract. Clinical presentations vary substantially among individuals, increasing the likelihood of misdiagnosis or missed diagnosis. In severe cases, if not properly managed, laryngeal edema can result in asphyxiation or even death. Here, we report a Chinese male patient who experienced recurrent limb swelling and abdominal pain. Laboratory tests revealed low levels of complement C4 and C1 inhibitors, along with impaired C1 inhibitor function. Genomic DNA extracted from peripheral blood samples underwent PCR amplification and Sanger sequencing, which identified a <i>de novo</i> heterozygous mutation in the <i>SERPING1</i> gene at chr11:57379227, confirming a novel missense mutation NM_000062.c.1067T > A (p.V356E). Ultimately, the patient was diagnosed with HAE-C1INH-Type1 and successfully protected from recurrent attacks through subcutaneous administration of lanadelumab.</p>","PeriodicalId":73062,"journal":{"name":"Frontiers in allergy","volume":"6 ","pages":"1554940"},"PeriodicalIF":3.3000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12069465/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in allergy","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3389/falgy.2025.1554940","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Hereditary angioedema (HAE) is a rare autosomal dominant genetic disorder characterized by recurrent, unpredictable episodes of angioedema that commonly involve the face, limbs, respiratory tract, and gastrointestinal tract. Clinical presentations vary substantially among individuals, increasing the likelihood of misdiagnosis or missed diagnosis. In severe cases, if not properly managed, laryngeal edema can result in asphyxiation or even death. Here, we report a Chinese male patient who experienced recurrent limb swelling and abdominal pain. Laboratory tests revealed low levels of complement C4 and C1 inhibitors, along with impaired C1 inhibitor function. Genomic DNA extracted from peripheral blood samples underwent PCR amplification and Sanger sequencing, which identified a de novo heterozygous mutation in the SERPING1 gene at chr11:57379227, confirming a novel missense mutation NM_000062.c.1067T > A (p.V356E). Ultimately, the patient was diagnosed with HAE-C1INH-Type1 and successfully protected from recurrent attacks through subcutaneous administration of lanadelumab.
遗传性血管性水肿(HAE)是一种罕见的常染色体显性遗传病,其特征是反复发作,不可预测的血管性水肿,通常累及面部、四肢、呼吸道和胃肠道。临床表现在个体之间差异很大,增加了误诊或漏诊的可能性。在严重的情况下,如果处理不当,喉部水肿可导致窒息甚至死亡。在这里,我们报告一位中国男性患者,他经历了反复的肢体肿胀和腹部疼痛。实验室测试显示补体C4和C1抑制剂水平低,同时C1抑制剂功能受损。从外周血样本中提取的基因组DNA进行PCR扩增和Sanger测序,鉴定出SERPING1基因chr11:57379227的新生杂合突变,确认了一个新的错义突变NM_000062.c。1067T > A (p.V356E)。最终,患者被诊断为HAE-C1INH-Type1,并通过皮下给药lanadelumab成功地防止了复发性发作。